Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How AstraZeneca Flubbed Its Better-Than-Expected COVID Vaccine Update

TheMotleyFool

0 0

How AstraZeneca Flubbed Its Better-Than-Expected COVID Vaccine Update

AstraZeneca's (NASDAQ: AZN) release of efficacy results for its COVID-19 vaccine turned into something of a soap opera. The company received a rare criticism from the National Institutes of Health (NIH) after first announcing its interim results. In this Motley Fool Live video recorded on March 24, 2021, Motley Fool contributors Keith Speights and Brian Orelli talk about how AstraZeneca flubbed its better-than-expected COVID vaccine update. (Note: AstraZeneca subsequently released updated efficacy results on March 25 after this video was recorded.)

Source Fool.com

Like: 0

AZN

Share